As much as some open questions and challenges remain out in front, the data reviewed here are encouraging and demonstrate the potential of therapeutic efforts of tau-based strategies for the future treatment of tauopathies, including AD, either alone or in combination. This evidence concerns the gene MAPT and Alzheimer disease.